We further assessed the levels of IL-6 in CAF-conditioned media from different prostate cancer patients by ELISA and detected IL-6 at concentrations between 0.25 and 0.60 ng/mL in the CAF-conditioned media, while LNCaP did not produce any detectable IL-6 (Fig. 1b). Here, IL6 is linked to prostate carcinoma.